I have the unique privilege of being able to look at the purchasing behavior of 150,000 representative US households, asking these households whether at least one household member is on a GLP-1 drug, and then seeing how their purchases change before they’re on GLP-1s, while they’re on GLP-1s, and after they stop taking GLP-1s.
The results are fascinating, and I had the opportunity to share some of them with Catherine Rampell on PBS News Hour:
American Consumer 